Douglas S. Ross, MD | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
Healthcare Professionals

Douglas S. Ross, MD

Healthcare Professional
Co-Director
Thyroid Associates Practice
Massachusetts General Hospital
15 Parkman Street
Boston, Massachusetts, United States

Douglas S. Ross is a Co-director of Thyroid Associates Practice at Massachusetts General Hospital and a Professor of Medicine at Harvard Medical School. He graduated from Harvard Medical School in 1977, completed his internal medicine residency and endocrine fellowship training at the Massachusetts General Hospital. His endocrine practice concentrates on thyroid disorders, with an emphasis on hyperthyroidism, thyroid cancer and thyroid nodules. Procedures include radioiodine treatment for hyperthyroidism and thyroid cancer, and ultrasound-guided fine needle aspiration of thyroid nodules.

Dr. Ross is board certified in internal medicine, endocrinology and diabetes and metabolism. His specialties are cancer risk assessment, endocrine tumors, parathyroid tumors and thyroid tumors.

Dr. Ross has recently done outcome research for patients with micropapillary thyroid cancer using the National Thyroid Cancer Treatment Cooperative Study Group. He also has numerous publications in peer-reviewed journals, several of which involve outcome analysis for the National Thyroid Cancer Treatment Cooperative Study Group.

Dr. Ross is a busy clinician and sees up to 60 patients a week at Massachusetts General Hospital, including weekly sessions with endocrine fellows, medical residents, and students. In summary, Dr. Douglas Ross is a highly accomplished clinician, scholar, teacher and educator. 

 

Representative Publications:

Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for the Health Care System

Utility of Biochemical Markers of Bone Turnover in the Follow-Up of Patients Treated With Bisphosphonates

Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

Diagnostic Yield of Nondiagnostic Thyroid Nodules is Not Altered by Timing of Repeat Biopsy

rareRelated

Font Resize

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close